Photo taken from Kai Rejeski/X
Apr 13, 2024, 10:00
Kai Rejeski: The clinical impact of the new European Hematology Association The EBMT grading of immune effector cell-associated hematotoxicity
Kai Rejeski, Postdoctoral Researcher at the Gene Center, Ludwig-Maximilians-University, shared a post on X:
“Great to see this out in print in Blood Advances! Check out our study examining the clinical impact of the new European Hematology Association The EBMT grading of immune effector cell-associated hematotoxicity in a cohort of ~550 CAR T cell patients. We think that this study supports integrating the ICAHT grading system in new clinical trials evaluating CAR-T products ”
Read further.
Source: Kai Rejeski/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43